Join Fund Library now and get free access to personalized features to help you manage your investments.

Portland Life Sciences Alternative Fund Series A

Alternative Equity Focus

FundGrade A Click for more information on Fundata’s FundGrade

FundGrade A

Click for more information on Fundata’s FundGrade.

Fundata ESG GradeE Click for more information on Fundata’s ESG Grade

Fundata ESG Grade E

Click for more information on Fundata’s ESG Grade.

NAVPS
(05-24-2024)
$17.36
Change
$0.04 (0.23%)

As at April 30, 2024

As at April 30, 2024

As at February 29, 2024

Period
Loading...

Legend

Portland Life Sciences Alternative Fund Series A

Compare Options


Fund Returns

Inception Return (April 14, 2021): 16.41%

Fund Returns
Row Heading Return Annualized Return
1 Mth 3 Mth 6 Mth YTD 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr
Fund 4.16% 14.74% 43.52% 19.43% 41.40% 29.28% 16.99% - - - - - - -
Benchmark -1.82% 4.10% 16.91% 4.68% 8.73% 5.66% 7.59% 13.51% 8.86% 8.98% 8.12% 8.95% 7.25% 7.22%
Category Average -1.21% 14.78% 14.78% 6.99% 12.27% 5.96% 4.33% 9.27% 5.98% - - - - -
Category Rank 16 / 193 13 / 181 2 / 167 4 / 167 6 / 156 2 / 131 4 / 101 - - - - - - -
Quartile Ranking 1 1 1 1 1 1 1 - - - - - - -

Monthly Return

Monthly Return
Return % May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr
Fund 4.33% -1.85% 5.90% -2.25% -4.63% -2.55% 11.25% 8.01% 4.09% 9.72% 0.40% 4.16%
Benchmark -4.95% 3.36% 2.58% -1.37% -3.33% -3.21% 7.48% 3.91% 0.55% 1.82% 4.14% -1.82%

Best Monthly Return Since Inception

12.48% (July 2022)

Worst Monthly Return Since Inception

-5.62% (December 2022)

Calendar Return (%)

Calendar Return
Return % 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fund - - - - - - - - -1.20% 30.77%
Benchmark 10.55% -8.32% 21.08% 9.10% -8.89% 22.88% 5.60% 25.09% -5.84% 11.75%
Category Average - - - - - - 5.11% 17.27% -5.96% 6.54%
Quartile Ranking - - - - - - - - 2 1
Category Rank - - - - - - - - 37/ 120 16/ 150

Best Calendar Return (Last 10 years)

30.77% (2023)

Worst Calendar Return (Last 10 years)

-1.20% (2022)

Asset Allocation

Asset Allocation
Name Percent
US Equity 49.87
International Equity 37.74
Cash and Equivalents 12.41
Other -0.02

Sector Allocation

Sector Allocation
Name Percent
Healthcare 85.44
Cash and Cash Equivalent 12.41
Technology 2.17
Other -0.02

Geographic Allocation

Geographic Allocation
Name Percent
North America 62.28
Asia 37.74
Other -0.02

Top Holdings

Top Holdings
Name Percent
Telix Pharmaceuticals Ltd 20.74
Clarity Pharmaceuticals Ltd 12.90
Lantheus Holdings Inc 11.83
IsoRay Inc 10.23
Canada Government 0.00% 23-May-2024 5.15
Amgen Inc 4.87
BridgeBio Pharma Inc 4.55
Iovance Biotherapeutics Inc 4.19
Beigene Ltd - ADR 4.10
Global X Cash Maximizer CC ETF (HSAV) 4.07

Equity Style

Market capitalization is medium. Equity style is growth.

Fixed Income Style

Fixed income style data not available
Period: 

Risk vs Return (3 Yr)

Portland Life Sciences Alternative Fund Series A

Median

Other - Alternative Equity Focus

3 Yr Annualized

Standard Deviation 15.75% - -
Beta 0.63% - -
Alpha 0.12% - -
Rsquared 0.29% - -
Sharpe 0.90% - -
Sortino 1.96% - -
Treynor 0.23% - -
Tax Efficiency - - -
Volatility Volatility rating is 8 on a scale of 1 to 10 - -

Risk Rating

Rating 8 out of ten

Annualized Key Ratio Period Comparison

Key Ratio
Key Ratio 1 Yr 3 Yr 5 Yr 10 Yr
Standard Deviation 18.03% 15.75% - -
Beta 0.75% 0.63% - -
Alpha 0.30% 0.12% - -
Rsquared 0.29% 0.29% - -
Sharpe 1.76% 0.90% - -
Sortino 5.17% 1.96% - -
Treynor 0.42% 0.23% - -
Tax Efficiency 100.00% - - -

Fundata ESG Metrics

Fundata ESG Score

The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.

Fundata E Score

Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.

Fundata S Score

Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.

Fundata G Score

Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.

Powered by OWL Analytics. For more information, please contact Fundata Canada.

Fund Details

Start Date April 14, 2021
Instrument Type Mutual Fund (Alternative)
Share Class Commission Based Advice
Legal Status Trust
Sales Status Open
Currency CAD
Distribution Frequency Annual
Assets ($mil) $8

Fund Codes

FundServ Code Load Code Sales Status
PTL320
PTL325
PTL330

Investment Objectives

The Fund’s objective is to provide positive long-term total returns by investing primarily in a portfolio of securities focused on companies active in the healthcare sector. The Fund may also engage in borrowing for investment purposes. The Fund’s aggregate exposure shall not exceed limits on the use of gross exposure or as otherwise permitted under applicable securities legislation.

Investment Strategy

The Fund seeks to provide capital growth by primarily investing in a portfolio of equities, ADRs and may also invest in ETFs. The Fund’s investments currently focus on the area of precision oncology. The Fund also may invest in income trusts, debt securities convertible into common stock, convertible and non-convertible preferred stock, debt-like securities and fixed/floating income securities of governments, government agencies, supranational agencies, companies, trusts and limited partnerships

Portfolio Manager(s)

Name Start Date
Michael Lee-Chin 04-13-2021
Dragos Berbecel 04-14-2021

Management and Organization

Fund Manager Portland Investment Counsel Inc.
Advisor Portland Investment Counsel Inc.
Custodian CIBC Mellon Trust Company
Registrar CIBC Mellon Global Securities Services Company
Distributor Mandeville Private Client Inc.
Auditor KPMG LLP

Investment Minimums

RSP Eligible Yes
PAC Allowed Yes
PAC Initial Investment 50
PAC Subsequent 50
SWP Allowed Yes
SWP Min Balance 5,000
SWP Min Withdrawal 50

Fees

MER 4.74%
Management Fee 1.75%
Load Choice of Front or No Load
FE Max 6.00%
DSC Max -
Trailer Fee Max (FE) 1.00%
Trailer Fee Max (DSC) -
Trailer Fee Max (NL) -
Trailer Fee Max (LL) -

Join Fund Library now and get free access to personalized features to help you manage your investments.